# "Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat

> **NCT00377975** · PHASE2 · COMPLETED · sponsor: **Pennington Biomedical Research Center** · enrollment: 96 (—)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Ephedrine
- **DRUG:** Pioglitazone
- **DRUG:** Caffeine

## Key facts

- **NCT ID:** NCT00377975
- **Lead sponsor:** Pennington Biomedical Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2004-11
- **Target enrollment:** 96 (—)
- **Last updated:** 2016-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00377975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00377975, ""Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00377975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*